Rapid weight loss associated with GLP-1 based injections is causing facial skin laxity and increased hair shedding in some users [1].
These physical changes are significant because they alter a patient's appearance and can signal underlying nutritional deficiencies or medical conditions that require professional intervention.
Reports published in Brazil between June and July 2026 highlight a growing trend of facial flaccidity among users of "weight-loss pens" [1], [2]. This sagging occurs when the rapid loss of subcutaneous fat reduces the structural support for the skin, leaving the face appearing sunken or loose [1].
Beyond skin elasticity, some users are experiencing increased hair loss [3]. This shedding is often triggered by the physiological stress placed on hair follicles during extreme weight fluctuations, or resulting from nutritional deficits [3].
Medical professionals said that these symptoms do not always stem from the weight loss itself. Some indicators—such as hair loss combined with facial swelling and cold intolerance—may instead point to hypothyroidism [4]. Because these conditions can mimic the side effects of rapid weight loss, medical evaluation is advised to determine the exact cause.
In response to these trends, some Brazilian beauty brands have launched product lines specifically focused on skin firmness to address the aftermath of rapid weight loss [5]. However, clinicians said that topical treatments may not address the internal nutritional gaps causing the issues.
Patients are encouraged to maintain medical supervision while using GLP-1 medications to monitor for these side effects [1], [3]. Ensuring adequate nutrient intake is critical to mitigating the impact on skin and hair follicles during the weight-loss process [3].
“Rapid loss of subcutaneous fat reduces structural support for skin, causing sagging.”
The emergence of 'weight-loss face' and associated hair loss highlights a gap between the primary goal of GLP-1 medications—weight reduction—and the secondary aesthetic and physiological consequences. As these drugs become more common, the medical community must shift focus toward holistic management, including nutritional support and dermatological care, to prevent permanent skin laxity and distinguish medication side effects from endocrine disorders like hypothyroidism.
